Victoria Sinibaldi

Research Associate

1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020
2018

Kidney cancer: Toxicity management, symptom control, and palliative care

Sinibaldi, V., Pratz, C. F. & Yankulina, O., Dec 20 2018, In : Journal of Clinical Oncology. 36, 36, p. 1-7 7 p.

Research output: Contribution to journalReview article

2017

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: An open-label, phase 2, multicohort study

Teply, B. A., Wang, H., Luber, B., Sullivan, R., Rifkind, I., Bruns, A., Spitz, A., DeCarli, M., Sinibaldi, V., Pratz, C. F., Lu, C., Silberstein, J. L., Luo, J., Schweizer, M. T., Drake, C. G., Carducci, M. A., Paller, C., Antonarakis, E., Eisenberger, M. & Denmeade, S. R., Jan 1 2017, (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journalArticle

2016

Is there a "trial effect" on outcome of patients with metastatic renal cell carcinoma treated with sunitinib?

Keizman, D., Rouvinov, K., Sella, A., Gottfried, M., Maimon, N., Kim, J. J., Eisenberger, M. A., Sinibaldi, V., Peer, A., Carducci, M. A., Mermershtain, W., Leibowitz-amit, R., Weitzen, R. & Berger, R., Jan 1 2016, In : Cancer Research and Treatment. 48, 1, p. 281-287 7 p.

Research output: Contribution to journalArticle

Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib

Keizman, D., Sarid, D., Lee, J. L., Sella, A., Gottfried, M., Hammers, H., Eisenberger, M., Carducci, M. A., Sinibaldi, V., Neiman, V., Rosenbaum, E., Peer, A., Neumann, A., Mermershtain, W., Rouvinov, K., Berger, R. & Yildiz, I., Oct 1 2016, In : Oncologist. 21, 10, p. 1212-1217 6 p.

Research output: Contribution to journalArticle

2015

Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma

Keizman, D., Ish-Shalom, M., Sella, A., Gottfried, M., Maimon, N., Peer, A., Hammers, H., Eisenberger, M., Sinibaldi, V., Neiman, V., Rosenbaum, E., Sarid, D., Mermershtain, W., Rouvinov, K., Berger, R. & Carducci, M. A., Nov 12 2015, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

2014

Active smokingmay negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treatedwith sunitinib

Keizman, D., Gottfried, M., Ish-Shalom, M., Maimon, N., Peer, A., Neumann, A., Hammers, H., Eisenberger, M. A., Sinibaldi, V., Pili, R., Hayat, H., Kovel, S., Sella, A., Boursi, B., Weitzen, R., Mermershtain, W., Rouvinov, K., Berger, R. & Carducci, M. A., Jan 22 2014, In : Oncologist. 19, 1, p. 51-60 10 p.

Research output: Contribution to journalArticle

American Cancer Society prostate cancer survivorship care guidelines

Skolarus, T. A., Wolf, A. M. D., Erb, N. L., Brooks, D. D., Rivers, B. M., Underwood, W., Salner, A. L., Zelefsky, M. J., Aragon-Ching, J. B., Slovin, S. F., Wittmann, D. A., Hoyt, M. A., Sinibaldi, V. J., Chodak, G., Pratt-Chapman, M. L. & Cowens-Alvarado, R. L., Jan 1 2014, In : CA Cancer Journal for Clinicians. 64, 4, p. 225-249 25 p.

Research output: Contribution to journalArticle

Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel

Peer, A., Gottfried, M., Sinibaldi, V., Carducci, M. A., Eisenberger, M. A., Sella, A., Leibowitz-Amit, R., Berger, R. & Keizman, D., Jan 1 2014, In : Prostate. 74, 4, p. 433-440 8 p.

Research output: Contribution to journalArticle

2012

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma

Keizman, D., Ish-Shalom, M., Pili, R., Hammers, H., Eisenberger, M. A., Sinibaldi, V., Boursi, B., Maimon, N., Gottfried, M., Hayat, H., Peer, A., Kovel, S., Sella, A., Berger, R. & Carducci, M. A., May 1 2012, In : European Journal of Cancer. 48, 7, p. 1031-1037 7 p.

Research output: Contribution to journalArticle

Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: Association with outcome and predictive nomogram

Keizman, D., Gottfried, M., Ish-Shalom, M., Maimon, N., Peer, A., Neumann, A., Rosenbaum, E., Kovel, S., Pili, R., Sinibaldi, V., Carducci, M. A., Hammers, H., Eisenberger, M. A. & Sella, A., Dec 31 2012, In : Oncologist. 17, 12, p. 1508-1514 7 p.

Research output: Contribution to journalArticle

2011

TNF-blockade in patients with advanced hormone refractory prostate cancer

Diaz, L. A., Messersmith, W., Sokoll, L., Sinibaldi, V., Moore, S., Carducci, M. & Eisenberger, M., Feb 1 2011, In : Investigational New Drugs. 29, 1, p. 192-194 3 p.

Research output: Contribution to journalArticle

2010

Lenalidomide in nonmetastatic biochemically relapsed prostate cancer: Results of a phase I/II double-blinded, randomized study

Keizman, D., Zahurak, M., Sinibaldi, V., Carducci, M., Denmeade, S., Drake, C., Pili, R., Antonarakis, E. S., Hudock, S. & Eisenberger, M., Nov 1 2010, In : Clinical Cancer Research. 16, 21, p. 5269-5276 8 p.

Research output: Contribution to journalArticle

2007

Docetaxel treatment in the elderly patient with hormone refractory prostate cancer.

Sinibaldi, V. J., 2007, In : Clinical interventions in aging. 2, 4, p. 555-560 6 p.

Research output: Contribution to journalReview article

2006

Phase II evaluation of docetaxel plus exisulind in patients with androgen independent prostate carcinoma

Sinibaldi, V. J., Elza-Brown, K., Schmidt, J., Eisenberger, M. A., Rosenbaum, E., Denmeade, S. R., Pili, R., Walczak, J., Baker, S. D., Zahurak, M. & Carducci, M. A., Aug 1 2006, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 29, 4, p. 395-398 4 p.

Research output: Contribution to journalArticle

The role of cytotoxic chemotherapy in prostate cancer: A critical reevaluation 20 years later

Eisenberger, M. A. & Sinibaldi, V. W., Dec 1 2006, In : ONCOLOGY. 20, 8, p. 853-862 10 p.

Research output: Contribution to journalReview article

2005

Marimastat in the treatment of patients with biochemically relapsed prostate cancer: A prospective randomized, double-blind, phase I/II trial

Rosenbaum, E., Zahurak, M., Sinibaldi, V., Carducci, M. A., Pili, R., Laufer, M., DeWeese, T. L. & Eisenberger, M. A., Jun 15 2005, In : Clinical Cancer Research. 11, 12, p. 4437-4443 7 p.

Research output: Contribution to journalArticle

2004

A Phase II Trial of Temozolomide and IFN-α in Patients with Advanced Renal Cell Carcinoma

Sunkara, U., Walczak, J. R., Summerson, L., Rogers, T., Eisenberger, M., Denmeade, S., Pili, R., Huff, C. A., Sinibaldi, V. & Carducci, M. A., Jan 1 2004, In : Journal of Interferon and Cytokine Research. 24, 1, p. 37-41 5 p.

Research output: Contribution to journalArticle

Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: Elevation of estradiol as possible mechanism of action

Eisenberger, M. A., Laufer, M., Vogelzang, N. J., Sartor, O., Thornton, D., Neubauer, B. L., Sinibaldi, V., Lieskovsky, G., Carducci, M. A., Zahurak, M. & Raghavan, D., Jan 2004, In : Urology. 63, 1, p. 114-119 6 p.

Research output: Contribution to journalArticle

2002

Atrasentan, an endothelin-receptor antagonist for refractory adenocarcinomas: Safety and pharmacokinetics

Carducci, M. A., Nelson, J. B., Bowling, M. K., Rogers, T., Eisenberger, M. A., Sinibaldi, V., Donehower, R., Leahy, T. L., Carr, R. A., Isaacson, J. D., Janus, T. J., Andre, A., Hosmane, B. S. & Padley, R. J., Apr 15 2002, In : Journal of Clinical Oncology. 20, 8, p. 2171-2180 10 p.

Research output: Contribution to journalArticle

Phase II evaluation of docetaxel plus one-day oral estramustine phosphate in the treatment of patients with androgen independent prostate carcinoma

Sinibaldi, V. J., Carducci, M. A., Moore-Cooper, S., Laufer, M., Zahurak, M. & Eisenberger, M. A., Mar 1 2002, In : Cancer. 94, 5, p. 1457-1465 9 p.

Research output: Contribution to journalArticle

2001

A phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule

Carducci, M. A., Gilbert, J., Bowling, M. K., Eisenberger, M. A., Sinibaldi, V., Grochow, L. B., Donehower, R. C., Carducci, M. A., Noe, D., Zabelina, Y., Chen, T. L. & Grochow, L. B., Jan 1 2001, In : Clinical Cancer Research. 7, 10, p. 3047-3055 9 p.

Research output: Contribution to journalArticle

Clinical conduct and nursing quality of life in prostate cancer

Sinibaldi, V. J. & Arzoomanian, R. Z., Jan 1 2001, In : Hematology/Oncology Clinics of North America. 15, 3, p. 573-581 9 p.

Research output: Contribution to journalArticle

2000

Complete androgen blockade for prostate cancer: What went wrong?

Laufer, M., Denmeade, S. R., Sinibaldi, V. J., Carducci, M. A. & Eisenberger, M. A., Jul 2000, In : Journal of Urology. 164, 1, p. 3-9 7 p.

Research output: Contribution to journalReview article

1999

Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate- specific antigen working group

Bubley, G. J., Carducci, M., Dahut, W., Dawson, N., Daliani, D., Eisenberger, M., Figg, W. D., Freidlin, B., Halabi, S., Hudes, G., Hussain, M., Kaplan, R., Myers, C., Oh, W., Petrylak, D. P., Reed, E., Roth, B., Sartor, O., Scher, H., Simons, J. & 6 others, Sinibaldi, V., Small, E. J., Smith, M. R., Trump, D. L., Vollmer, R. & Wilding, G., Nov 1999, In : Journal of Clinical Oncology. 17, 11, p. 3461-3467 7 p.

Research output: Contribution to journalArticle

1998

Evaluation of biomarkers of survival response in hormone-refractory prostate cancer patients treated with suramin

Sridhara, R., Eisenberger, M. A., Sinibaldi, V. J., Reyno, L. M. & Egorin, M. J., Jul 1 1998, In : Cancer Epidemiology Biomarkers and Prevention. 7, 7, p. 631-634 4 p.

Research output: Contribution to journalArticle

1996

A prospective study of suramin-induced peripheral neuropathy

Chaudhry, V., Eisenberger, M. A., Sinibaldi, V. J., Sheikh, K., Griffin, J. W. & Cornblath, D. R., Jan 1 1996, In : Brain. 119, 6, p. 2039-2052 14 p.

Research output: Contribution to journalArticle

1995

Combined carboplatin plus bleomycin and conventional radiotherapy for advanced carcinomas of the head and neck

Espinoza-Jacobs, M. C., Suntharalingam, M., Eisenberger, M., Sinibaldi, V. & Salazar, O. M., Jan 1 1995, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 18, 1, p. 52-55 4 p.

Research output: Contribution to journalArticle

Development and validation of a pharmacokinetically based fixed dosing scheme for suramin

Reyno, L. M., Egorin, M. J., Eisenberger, M. A., Sinibaldi, V. J., Zuhowski, E. G. & Sridhara, R., Sep 1995, In : Journal of Clinical Oncology. 13, 9, p. 2187-2195 9 p.

Research output: Contribution to journalArticle

Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy

Sridhara, R., Eisenberger, M. A., Sinibaldi, V. J., Reyno, L. M. & Egorin, M. J., Dec 1995, In : Journal of Clinical Oncology. 13, 12, p. 2944-2953 10 p.

Research output: Contribution to journalArticle

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer

Eisenberger, M. A., Sinibaldi, V. J., Reyno, L. M., Sridhara, R., Jodrell, D. I., Zuhowski, E. G., Tkaczuk, K. H., Lowitt, M. H., Hemady, R. K., Jacobs, S. C., VanEcho, D. & Egorin, M. J., Sep 1995, In : Journal of Clinical Oncology. 13, 9, p. 2174-2186 13 p.

Research output: Contribution to journalArticle

Suramin

Eisenberger, M. A., Sinibaldi, V. & Reyno, L., Jan 1 1995, In : Cancer practice. 3, 3, p. 187-189 3 p.

Research output: Contribution to journalShort survey

The experience with suramin in advanced prostate cancer

Eisenberger, M. A., Reyno, L., Sinibaldi, V., Sridhara, R., Carducci, M. & Egorin, M., Apr 1 1995, In : Cancer. 75, 7 S, p. 1927-1934 8 p.

Research output: Contribution to journalArticle

1994

Suramin: Development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer

Jodrell, D. I., Reyno, L. M., Sridhara, R., Eisenberger, M. A., Tkaczuk, K. H., Zuhowski, E. G., Sinibaldi, V. J., Novak, M. J. & Egorin, M. J., Jan 1994, In : Journal of Clinical Oncology. 12, 1, p. 166-175 10 p.

Research output: Contribution to journalArticle

1993

Suramin, an active drug for prostate cancer: Interim observations in a phase I trial

Eisenberger, M. A., Reyno, L. M., Jodrell, D. I., Sinibaldi, V. J., Tkaczuk, K. H., Sridhara, R., Zuhowski, E. G., Lowitt, M. H., Jacobs, S. C. & Egorin, M. J., Apr 21 1993, In : Journal of the National Cancer Institute. 85, 8, p. 611-621 11 p.

Research output: Contribution to journalArticle

1992

Approaches to optimal dosing of hexamethylene bisacetamide

Conley, B. A., Egorin, M. J., Sinibaldi, V., Sewack, G., Kloc, C., Roberts, L., Zuhowski, E. G., Forrest, A. & Van Echo, D. A., Jan 1 1992, In : Cancer Chemotherapy and Pharmacology. 31, 1, p. 37-45 9 p.

Research output: Contribution to journalArticle

Carboplatin in the treatment of squamous cell head and neck cancers

Aisner, J., Sinibaldi, V. & Eisenberger, M., Feb 1992, In : Seminars in oncology. 19, 1 SUPPL. 2, p. 60-65 6 p.

Research output: Contribution to journalArticle

Phase II trial of 5 day continuous intravenous infusion of 6-thioguanine in patients with recurrent and metastatic squamous cell carcinoma of the head and neck

Kruter, F., Eisenberger, M., Sinibaldi, V., Engstrom, C., Jacobs, M., Abrams, J., Belani, C., Gray, W. & Krasnow, S., Jun 1 1992, In : Investigational New Drugs. 10, 2, p. 89-91 3 p.

Research output: Contribution to journalArticle

Suramin interferes with measurements of total calcium and serum amylase by the Kodak Ektachem 700 analyzer and may inhibit liver enzyme activity

Gregory, L. C., Eisenberger, M., Sinibaldi, V. & Koch, T. R., Jan 1 1992, In : Clinical chemistry. 38, 12, p. 2552-2553 2 p.

Research output: Contribution to journalComment/debate

1990

Tolerance of full dose menogaril (NSC 269148) in patients with abnormal hepatic and renal function

Conley, B. A., Egorin, M. J., Sinibaldi, V. & Van Echo, D. A., Nov 1 1990, In : Investigational New Drugs. 8, 4, p. 365-367 3 p.

Research output: Contribution to journalArticle